Modulating the Immune System
Home
About
Active Biotech in Brief
Board of Directors
Management
Business Concept
Corporate Governance
Corporate Governance Report 2019
Article of Association
Audit committee
Scientific committee
Election Committee
General Meetings
Auditors
Partnerships
Career
Projects
Project Overview
Naptumomab
Tasquinimod
Laquinimod
Patents
Orphan Drug Designation
Investor
Investor
Analyst coverage
Financial Calendar
Financial Reports
Interim Reports
Annual Reports
Stock
Ownership
Official Documents
Rights Issue 2014
Rights Issue 2016
Rights Issue 2018
Rights Issue 2021
Media
Press Contact
Press Releases
Subscribe
News
Company Presentation
Image Bank
Contact
Copyright © 2021 Active Biotech AB.
All Rights Reserved.
Design by
Clavis Communications
.
Financial Calendar
May 19, 2021, Annual General Meeting
November 12, 2020
November 4, 2021, Interim report
November 12, 2020
August 5, 2021, Interim report
November 12, 2020
April 22, 2021, Interim report
November 12, 2020
May 19, 2020, Annual General Meeting
December 9, 2019
More info
February 11, 2021, Year-end report 2020
December 9, 2019
November 5, 2020, Interim report
December 9, 2019
August 6, 2020, Interim report
December 9, 2019
April 23, 2020, Interim report
December 9, 2019
April 4, 2019, Extraordinary shareholders’ meeting
March 13, 2019
More info
February 6, 2020, Year-end report 2019
November 27, 2018
November 14, 2019, Interim report
November 27, 2018
August 8, 2019, Interim report
November 27, 2018
May 23, 2019, Annual General Meeting
November 27, 2018
April 25, 2019, Interim report
November 27, 2018
February 14, 2019, Year-end report 2018
March 8, 2018
November 15, 2018, Interim report
March 8, 2018
August 9, 2018, Interim report
March 8, 2018
Annual General Meeting 2018
March 8, 2018
Read all information about the 2018 Annual General Meeting here.
Interim report
March 8, 2018
Extraordinary shareholders’ meeting
March 8, 2018
This site uses cookies.
Okay, thanks
